On October 25 of this year, the FDA published a draft for guidelines that would help expedite access to medical devices intended for treatment or diagnosis of life-threatening or irreversibly debilitating disease conditions. Industry experts have 60 days to submit comments and concerns of the draft and that day is coming up. To read more about the eligibility of a “breakthrough device” and how to leave comments, click here.